| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Zevra Therapeutics, Inc.'s insiders have reduced their positions by a net 74,966 shares worth roughly $838K. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 417.2K | $4.28M | -20,000 | |
| CFO | 143.5K | $1.47M | - | |
| Dir | 123.4K | $1.27M | - | |
| Other | 62.3K | $639.0K | - | |
| Other | 37.6K | $385.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Joshua Schafer53 | CCO | Sale+OE10b5-1 | 3,375 | $8.83 | $29,800.24 | -8.3% | +13.0% | - | |
| Jan 30, 2026 | Rahsaan Thompson | Chief Legal & Compliance | Sale+OE10b5-1 | 4,080 | $8.83 | $36,009.67 | -7.6% | +13.0% | - | |
| Jan 30, 2026 | Adrian W Quartel | Chief Medical Officer | Sale+OE10b5-1 | 4,533 | $8.83 | $40,035.91 | -31.8% | +13.0% | - | |
| Oct 10, 2025 | Neil F. McFarlane | President and CEO | Sale+OE10b5-1 | 19,500 | $10.82 | $210,908.10 | -8.1% | -21.6% | +3.5% | |
| Sep 12, 2025 | Tamara A Favorito69 | Director | Buy | 3,175 | $7.79 | $24,718.01 | +441.6% | +8.3% | +55.0% | |
| Sep 12, 2025 | Alvin Shih | Director | Buy | 20,000 | $7.89 | $157,800.00 | New | +8.3% | +55.0% | |
| Aug 19, 2025 | John B Bode67 | Director | Buy | 5,000 | $9.17 | $45,825.00 | +12.5% | +1.9% | +34.7% | |
| Jun 26, 2025 | Rahsaan Thompson | Chief Legal & Compliance | Sell10b5-1 | 24,000 | $9.21 | $221,004.00 | -36.0% | -3.6% | +45.7% | |
| Mar 28, 2025 | Corey Michael Watton46 | Director | Buy | 300 | $7.84 | $2,351.52 | +20.0% | +18.2% | +16.7% | |
| Mar 19, 2025 | John B Bode67 | Director | Buy | 10,000 | $7.96 | $79,624.00 | +33.3% | +10.8% | +18.2% |